QCOR Related Analyst EPS View
-
Favus Institutional Research Downgrades Questcor Pharmaceuticals (QCOR) to Sell
-
Oppenheimer Sees Upside in Shares of Jazz Pharmaceuticals (JAZZ)
-
Oppenheimer Maintains an 'Outperform' on Questcor Pharma (QCOR); Bringing In The Consultant
-
Oppenheimer Reiterates an 'Outperform' on Questcor Pharmaceuticals (QCOR); Expansion Strategy Into Rheumatology
-
Jefferies Raises Questcor Pharmaceuticals (QCOR) Price Target From $50 to $52
-
Jefferies Positive On Questcor Pharmaceuticals (QCOR) Following Q4 Results, Dispels Negative Rumors
Back to QCOR Stock Lookup
